Article: Mount Sinai Presents Trial Findings at 2009 Alzheimer's Association International Conference


Wireless News
07-15-2009
Mount Sinai Presents Trial Findings at 2009 Alzheimer's Association International Conference
Type: News

The results of a preliminary clinical trial suggest that a new Alzheimer's drug from Humanetics Corp. is safe for daily use and that cognitive performance in patients with mild to moderate disease remained stable during the six-week course of the trial, the company announced.

In a release, the company noted:
The lack of decline in cognitive performance was an encouraging finding to be further evaluated in a Phase IIB clinical trial.

Phase IIA clinical findings were presented in Vienna today at the 2009 Alzheimer's Association International Conference on ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!